Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol vs. Narcotics for Post Operative Pain Control in Knee Arthroscopy
NCT05934500Phase 1Withdrawn
- Sponsor
- Foundation for Orthopaedic Research and Education
- Start
- Oct 2023
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cannabidiol in postoperative pain (3 arms), sponsored by Foundation for Orthopaedic Research and Education. Primary endpoint: Post-operative pain control. Planned start Oct 2023; status: withdrawn.
02
Drugs
cannabidiol
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05934500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05934500.